BACKGROUND: The use of the SynCardia temporary total artificial heart (TAH-t) in adults has increased with time. The development of the smaller, 50 cc TAH-t has expanded the potential applications of the device in children. We sought to describe the evolving use of the TAH-t over time and describe outcomes in the current era. METHODS: The SynCardia database was queried to identify all pediatric patients ≤18 years of age implanted with the device between December 1985 and October 2019. Patient demographics, clinical outcome and support characteristics collected. RESULTS: Fifty-one children were supported, 36 with the 70 cc TAH-t and 15 with the 50 cc TAH-t with a total support time of 6,243 days. The number of implants has increased with time (19 between 2015 and 2019). A total of 13 patients have been converted to Freedom Driver support, seven 50 cc TAH-t and six 70 cc TAH-t. The majority of implants in the last 5 years (15/19, 79%) have been with the 50 cc TAH-t. The most common diagnosis was dilated cardiomyopathy [24 (47%)] and the average age at the time of implant was 16±2 years old. Overall survival for the patient cohort was 71%. CONCLUSIONS: The use of the SynCardia TAH-t to support children with end-stage heart failure has increased over time. Clinical outcomes with both the 50 cc and 70 cc TAH-t are similar to reported outcomes in adults who require TAH-t or other methods of biventricular support. 2020 Annals of Cardiothoracic Surgery. All rights reserved.
BACKGROUND: The use of the SynCardia temporary total artificial heart (TAH-t) in adults has increased with time. The development of the smaller, 50 cc TAH-t has expanded the potential applications of the device in children. We sought to describe the evolving use of the TAH-t over time and describe outcomes in the current era. METHODS: The SynCardia database was queried to identify all pediatric patients ≤18 years of age implanted with the device between December 1985 and October 2019. Patient demographics, clinical outcome and support characteristics collected. RESULTS: Fifty-one children were supported, 36 with the 70 cc TAH-t and 15 with the 50 cc TAH-t with a total support time of 6,243 days. The number of implants has increased with time (19 between 2015 and 2019). A total of 13 patients have been converted to Freedom Driver support, seven 50 cc TAH-t and six 70 cc TAH-t. The majority of implants in the last 5 years (15/19, 79%) have been with the 50 cc TAH-t. The most common diagnosis was dilated cardiomyopathy [24 (47%)] and the average age at the time of implant was 16±2 years old. Overall survival for the patient cohort was 71%. CONCLUSIONS: The use of the SynCardia TAH-t to support children with end-stage heart failure has increased over time. Clinical outcomes with both the 50 cc and 70 cc TAH-t are similar to reported outcomes in adults who require TAH-t or other methods of biventricular support. 2020 Annals of Cardiothoracic Surgery. All rights reserved.
Entities:
Keywords:
Total artificial heart; congenital heart disease; pediatrics
Authors: Juliane Vierecke; Brigitta Gahl; Theo M M H de By; Herwig Antretter; Friedhelm Beyersdorf; Kadir Caliskan; Valeriya Krachak; Antonio Loforte; Evgenij Potapov; Felix Schoenrath; Bernard Stockman; Marc Vanderheyden; Bart Meyns; Jan Gummert; Paul Mohacsi Journal: Eur J Cardiothorac Surg Date: 2019-12-01 Impact factor: 4.191
Authors: David L S Morales; Angela Lorts; Raheel Rizwan; Farhan Zafar; Francisco A Arabia; Chet R Villa Journal: ASAIO J Date: 2017 Jul/Aug Impact factor: 2.872
Authors: Joseph W Rossano; David J Goldberg; Stephanie Fuller; Chitra Ravishankar; Lisa M Montenegro; J William Gaynor Journal: Ann Thorac Surg Date: 2014-04 Impact factor: 4.330
Authors: Ryan A Moore; Angela Lorts; Peace C Madueme; Michael D Taylor; David L S Morales Journal: J Heart Lung Transplant Date: 2016-01-08 Impact factor: 10.247
Authors: Francisco A Arabía; Ryan S Cantor; Devin A Koehl; Vigneshwar Kasirajan; Igor Gregoric; Jaime D Moriguchi; Fardad Esmailian; Danny Ramzy; Joshua S Chung; Lawrence S Czer; Jon A Kobashigawa; Richard G Smith; James K Kirklin Journal: J Heart Lung Transplant Date: 2018-04-26 Impact factor: 10.247
Authors: Jennifer Conway; Oliver Miera; Iki Adachi; Katsuhide Maeda; Pirooz Eghtesady; Heather T Henderson; Kristine Guleserian; Chu-Po S Fan; Richard Kirk Journal: Semin Thorac Cardiovasc Surg Date: 2018-03-15
Authors: Jack G Copeland; Richard G Smith; Francisco A Arabia; Paul E Nolan; Gulshan K Sethi; Pei H Tsau; Douglas McClellan; Marvin J Slepian Journal: N Engl J Med Date: 2004-08-26 Impact factor: 91.245
Authors: Joshua M Friedland-Little; Anna Joong; Svetlana B Shugh; Matthew J O'Connor; Neha Bansal; Ryan R Davies; Michelle S Ploutz Journal: Pediatr Cardiol Date: 2022-03-24 Impact factor: 1.838